GGTClass II
Assay, Erythropoietin
21 CFR 864.7250 / Hematology
GGT is the FDA product code for Assay, Erythropoietin, a class II device type, regulated under 21 CFR 864.7250. As of , FDA records hold 20 510(k) clearances under this code, the most recent dated , and 5 recalls.
Classification record
- Product code
- GGT
- Device name
- Assay, Erythropoietin
- Regulation
- 21 CFR 864.7250
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 20
- Ingested recalls
- 5
Clearances, product code GGT
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1984 | 1 |
| 1988 | 1 |
| 1989 | 2 |
| 1990 | 2 |
| 1991 | 1 |
| 1993 | 2 |
| 1994 | 3 |
| 1996 | 2 |
| 1999 | 2 |
| 2000 | 1 |
| 2006 | 1 |
| 2019 | 1 |
| 2024 | 1 |
Applicants with the most clearances
Product code GGT| Applicant | Clearances |
|---|---|
| Siemens Healthcare Diagnostics Inc. | 3 |
| R & D Systems, Inc. | 3 |
| Amgen, Inc. | 2 |
| Genzyme Corporation | 2 |
| Incstar Corp. | 2 |
| Nichols Institute | 2 |
| Axis-Shield Diagnostics, Ltd. | 1 |
| Diagnostic Systems Laboratories, Inc. | 1 |
| Jcl Clinical Research Corp. | 1 |
| Nichols Institute Diagnostics | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
